JUNS
NASDAQ
$0.17
Jupiter Neurosciences Inc (JUNS)
Jupiter Neurosciences, Inc., a clinical stage research and development pharmaceutical company, develops resveratrol platform products primarily for the treatment of neuroinflammation. The company is headquartered in Jupiter, Florida.
Sector:
Healthcare
Industry:
Biotechnology
Target: $30 (+18081.82%)
Market Cap
$6.48M
Free Cash Flow Yield
-69.14%
Beta (5Y)
0.29
Price Chart
Valuation
Market Cap$6.48M
Forward P/E6.97
P/S212.82
P/B227.66
Profitability
Total Revenue (TTM)$40K
Gross Profit (TTM)-$2M
EBITDA-$8.99M
Operating Margin-10524%
EPS-$0.26
Financial Health
Free Cash Flow Yield-69.14%
Growth & Risk
Beta (5Y)0.29
Sharpe Ratio-1.60